Literature DB >> 11379635

Intraductal papillary-mucinous tumor of the pancreas: assessing the grade of malignancy from natural history.

K Yamaguchi1, A Sugitani, K Chijiiwa, M Tanaka.   

Abstract

Intraductal papillary-mucinous tumor of the pancreas is a spectrum of conditions ranging from benign to malignant, and very few papers have referred to the natural history of this disease. In this communication the indicators of malignancy were examined from a viewpoint of natural history. Follow-up computed tomographies (CTs) more than 6 months after the diagnosis were reviewed in 17 Japanese patients with intraductal papillary-mucinous tumor of the pancreas. They were divided into two groups by the presence or absence of morphological progressive changes by the follow-up CTs, and the clinicopathological features were compared between the two groups to examine possible malignant indicators. The 17 patients consisted of seven patients in the no-change group and ten in the progressive group. The distribution of the patients was not different with regard to age; gender; or presence or absence of pancreatitis, diabetes mellitus, or unique findings of the ampulla of Vater between the two groups. The dilatation of the main pancreatic duct (> or = 3 mm) was more frequent in the progressive group: (eight of ten patients; 80%) than in the no-change group (two of seven patients; 29%) (P = 0.03). Six (86%) of the seven tumors in the no-change group were located in the branch duct, whereas five (50%) of the ten in the progressive group were situated in the main pancreatic duct. Histopathologic diagnoses of the resected specimens of the four in the no-change group examined were intraductal papillary-mucinous adenoma in three and adenoma with moderate dysplasia in one, whereas the diagnoses in the six in the progressive group examined were adenoma in two, adenoma with moderate dysplasia in two, and carcinoma (invasive) in two. The patients with intraductal papillary-mucinous tumor of the pancreas with a dilatation of the main pancreatic duct at the time of diagnosis should be followed up more carefully than those without dilatation. Once progressive morphological changes are detected by the follow-up CTs surgical resection should be considered because of possible malignancy.

Entities:  

Mesh:

Year:  2001        PMID: 11379635

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  11 in total

Review 1.  Ultrasonographic findings and natural history of intraductal papillary-mucinous neoplasms of the pancreas.

Authors:  Go Kobayashi; Naotaka Fujita; Yutaka Noda; Takashi Obana; Osamu Takasawa
Journal:  J Med Ultrason (2001)       Date:  2008-09-19       Impact factor: 1.314

2.  Metachronous intraductal papillary mucinous neoplasm with carcinoma in situ of the pancreas arising within a short interval: report of a case.

Authors:  Yuji Watanabe; Atsushi Horiuchi; Koichi Sato; Shungo Yukumi; Hiroki Sugishita; Motohira Yoshida; Takashi Doi; Yuji Yamamoto; Naoki Ishida; Kazuhiro Kameoka; Kanji Kawachi
Journal:  Surg Today       Date:  2010-04-28       Impact factor: 2.549

3.  Noninvasive intraductal papillary mucinous neoplasm with para-aortic lymph node metastasis: report of a case.

Authors:  Kazuyuki Nagai; Ryuichiro Doi; Masayuki Koizumi; Toshihiko Masui; Yoshiya Kawaguchi; Akihiko Yoshizawa; Shinji Uemoto
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

4.  Natural history of intraductal papillary mucinous neoplasia: How much do we really know?

Authors:  Chad G Ball; Thomas J Howard
Journal:  World J Gastrointest Surg       Date:  2010-10-27

5.  An analysis of clinico-pathologic features of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Wenhui Lou; Dayong Jin; Dansong Wang; Xuefeng Xu; Tiantao Kuang; Xinyu Qin
Journal:  Front Med China       Date:  2007-02-01

6.  In vivo and in vitro propagation of intraductal papillary mucinous neoplasms.

Authors:  Hirohiko Kamiyama; Mihoko Kamiyama; Seung-Mo Hong; Collins A Karikari; Ming-Tseh Lin; Michael W Borges; Margaret Griffith; Angela Young; Alexis Norris-Kirby; Conrad Lubek; Masamichi Mizuma; Georg Feldmann; Chanjuan Shi; Hong Liang; Michael G Goggins; Anirban Maitra; Ralph H Hruban; James R Eshleman
Journal:  Lab Invest       Date:  2010-03-15       Impact factor: 5.662

7.  Main-duct intraductal papillary mucinous adenoma of the pancreas with a large mural nodule.

Authors:  Koki Nagaike; Kazuo Chijiiwa; Masahide Hiyoshi; Jiro Ohuchida; Hiroaki Kataoka
Journal:  Int J Clin Oncol       Date:  2007-10-22       Impact factor: 3.402

Review 8.  Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management.

Authors:  Claudio Bassi; Michael G Sarr; Keith D Lillemoe; Howard A Reber
Journal:  J Gastrointest Surg       Date:  2007-12-19       Impact factor: 3.452

9.  Small invasive ductal carcinoma of the pancreas distinct from branch duct intraductal papillary mucinous neoplasm.

Authors:  Hiroki Sakamoto; Masayuki Kitano; Takamitsu Komaki; Hajime Imai; Ken Kamata; Masatomo Kimura; Yoshifumi Takeyama; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2009-11-21       Impact factor: 5.742

10.  Natural history of branch duct intraductal papillary mucinous neoplasm with mural nodules: a Japan Pancreas Society multicenter study.

Authors:  Go Kobayashi; Naotaka Fujita; Hiroyuki Maguchi; Satoshi Tanno; Nobumasa Mizuno; Keiji Hanada; Takashi Hatori; Yoshihiko Sadakari; Taketo Yamaguchi; Kousuke Tobita; Ryuichiro Doi; Akio Yanagisawa; Masao Tanaka
Journal:  Pancreas       Date:  2014-05       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.